Kidney disease statistics for India
This is a citation reference: every figure names its source and year so writers can check it and parents and families can trust it. Figures are reviewed again on or before 2026-10-05.
Burden of chronic kidney disease
Published population studies give the clearest picture of how common chronic kidney disease (CKD) is among adults in India. These are screening-estimate figures and present the size of the problem, not routine diagnosis counts.
Source: Singh AK, Farag YM, Mittal BV, et al. Chronic kidney disease in the Delhi adult population (Kidney International, 2013). (year: 2013) — open source. A landmark community-screening estimate of CKD in India; widely cited in nephrology literature.
Source: GBD 2019 — Global Burden of Disease renal estimates, The Lancet. (year: 2019) — open source. India carries one of the largest national shares of this global burden.
Source: International Diabetes Federation Diabetes Atlas. (year: 2021) — open source. Diabetic kidney disease is the leading cause of end-stage kidney disease in India; hypertension is the other major driver.
Diagnosis and treatment access
The gap between who needs treatment and who receives it is the largest single problem in Indian kidney care. The figures below come from healthcare-access studies and national registries.
Source: National and international nephrology population estimates (screened-treatment-gap analyses reported across ISN and ICMR literature). (year: 2015–2023) — open source. Consistently cited estimate: most people with end-stage kidney disease in India never initiate renal replacement therapy.
Source: State-level CKD screening studies reported in Indian Journal of Nephrology and Kidney International Reports. (year: 2019–2023) — open source. Regional figures vary with age distribution and diabetes burden; they reinforce that CKD is common and often undiagnosed.
Source: Ministry of Health & Family Welfare, NP-NCD programme documentation. (year: 2016–2023) — open source. Access is improving, but the conversation with families remains: prevention and early testing prevent most CKD progression.
Transplantation and donation
Transplantation is the most successful treatment for end-stage kidney disease. India's own data, published by its national transplant organisation, is the reference everyone cites.
Source: National Organ & Tissue Transplant Organisation (NOTTO) — national donation statistics reported by MoHFW. (year: 2023) — open source. The number is growing year on year; it remains far below the country's transplant need. The nephron network is donation-education, never commerce.
Source: NOTTO / Indian Society of Nephrology transplant registry summaries. (year: 2020–2023) — open source. India's transplant system is built on regulated living donation under THOTA. Never buy, never sell — donation is altruistic and only through approved pathways.
Source: Transplantation of Human Organs and Tissues Act, 1994 (as amended), Ministry of Law. (year: 1994) — open source. The law governs both living and deceased donation; the NOTTO website carries the current rules and procedures.